Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Cangene's newest hyperimmune agent targets hepatitis C

Dec. 19, 2000

Schering-Plough seeks additional FDA approval for Rebetol capsules

Dec. 18, 2000

Gilead cleared to test adefovir dipivoxil for HBV in the clinic in China

Dec. 15, 2000

New agents for H. pylori-related disorders patented by Takeda

Dec. 14, 2000

Taisho discovers new histamine H2 antagonist with antisecretory activity

Dec. 13, 2000

FDA approves new indications for Prevacid

Dec. 12, 2000

Phase I trial of new treatment for HCV and associated liver cancer cleared in Israel

Dec. 4, 2000

Nitric oxide synthase inhibitors for inflammation and pain described by AstraZeneca

Nov. 30, 2000

Secondary efficacy measures improved by ISIS-2302 treatment in Crohn's disease

Nov. 30, 2000

New target for IBD treatment discussed at UEGW: leukocyte-platelet aggregation

Nov. 30, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...